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ABSTRACT 27 
We investigated the effect of activating metabolically sensitive skeletal muscle afferents (muscle 28 
metaboreflex) on cerebral blood flow and the potentially confounding influence of concomitant changes 29 
in the partial pressure of arterial carbon dioxide. Eleven healthy males (25±4 years) performed 30 
submaximal leg cycling exercise on a semi-recumbent cycle ergometer (heart rate ~120 bmin-1), and 31 
assessments made of the partial pressure of end-tidal carbon dioxide (PETCO2), internal carotid artery 32 
blood flow (ICAQ) and conductance (ICACVC), middle cerebral artery mean blood velocity (MCAVm) 33 
and conductance index (MCACVCi).The muscle metaboreflex was activated during cycling with leg 34 
blood flow restriction (BFR) or isolated with post exercise ischemia (PEI). In separate trials, PETCO2 35 
was either permitted to fluctuate spontaneously (control trial) or was clamped at 1 mmHg above resting 36 
levels (PETCO2 clamp trial). In the control trial, leg cycling with BFR decreased PETCO2 (Δ-4.8±0.9 37 
mmHg vs. leg cycling exercise) secondary to hyperventilation, while ICAQ, ICACVC, and MCAVm were 38 
unchanged, and MCACVCi decreased. However, in the PETCO2 clamp trial, leg cycling with BFR 39 
increased both MCAVm (Δ5.9±1.4 cm∙s-1) and ICAQ (Δ20.0±7.8 ml∙min-1), and attenuated the decrease 40 
in MCACVCi, while ICACVC was unchanged. In the control trial, PEI decreased PETCO2 (Δ-7.0±1.3 41 
mmHg vs. rest), MCAVm and MCACVCi, whereas ICAQ and ICACVC were unchanged. In contrast, in the 42 
PETCO2 clamp trial both ICAQ (Δ18.5±11.9 ml∙min-1) and MCAVm (Δ8.8±2.0 cm∙s-1) were elevated, 43 
while ICACVC and MCACVCi were unchanged. In conclusion, when hyperventilation-related decreases in 44 
PETCO2 are prevented the activation of metabolically sensitive skeletal muscle afferent fibres increases 45 
cerebral blood flow. 46 
New & Noteworthy: Muscle metaboreflex activation increases cerebral blood flow, but only when 47 
hyperventilation mediated reductions in the partial pressure of end-tidal carbon dioxide are prevented. 48 
These findings may have implications for individuals practicing exercise training with blood flow 49 
restriction and patient populations in whom exaggerated muscle metaboreflex sensitivity has been 50 
identified. 51 
Key words:  cerebrovascular circulation; exercise; metabolic activation  52 
INTRODUCTION 53 
Increases in cerebral blood flow during exercise are associated with upsurges in brain activation 54 
and metabolism within regions such as the motor-sensory cortex and supplementary motor area (23). 55 
Several other interacting mechanisms also contribute to the cerebral circulatory response accompanying 56 
exercise, including chemical, hemodynamic, autoregulatory and neural factors (42). The stimulation of 57 
group III and IV skeletal muscle afferents has also been implicated in the cerebral blood flow responses 58 
to exercise, but this remains incompletely understood (19, 20, 27). Group III and IV skeletal muscle 59 
afferents are responsive to metabolic (muscle metaboreflex) and mechanical (muscle mechanoreflex) 60 
perturbation. Alongside central command (feedforward signals from higher brain centres) and the 61 
arterial and cardiopulmonary baroreceptors, group III and IV skeletal muscle afferents play a key role in 62 
mediating the cardiovascular adjustments to exercise (18). Early studies established two approaches for 63 
the assessment of the muscle metaboreflex (3, 4, 52). The first approach involved blood flow restriction 64 
(BFR) to the exercising muscles using proximally placed inflatable occlusion cuffs, in order to create a 65 
mismatch between oxygen delivery and demand. This in turn evoked an accelerated accumulation of 66 
exercise-induced metabolites and enhanced activation of the metabolically sensitive skeletal muscle 67 
afferents. The second approach involved the complete circulatory arrest of the exercising skeletal 68 
muscle continuing into the recovery period while the muscle is quiescent (i.e., post-exercise ischemia; 69 
PEI). In this manner, metabolically sensitive skeletal muscle afferents may be activated in isolation by 70 
the trapping of exercise-induced metabolites within the muscle.  71 
During the isolated activation of the muscle metaboreflex with PEI following handgrip, exercise-72 
induced increases in middle cerebral artery (MCA) mean blood velocity (Vm) are not sustained and 73 
MCAVm returns to baseline (28, 46). This is in conflict with reports that the use of local anaesthesia to 74 
block sensory feedback from group III and IV skeletal muscle afferent fibres abolished the normal 75 
increase of MCAVm during static and dynamic handgrip (19, 20, 27). We recently observed that such 76 
contradictory reports may be attributable to muscle metaboreflex mediated increases in ventilation 77 
during PEI, which lead to a confounding reduction in the partial pressure of arterial carbon dioxide 78 
(PaCO2; indexed by the partial pressure of end-tidal carbon dioxide; PETCO2) and a cerebral 79 
vasoconstriction that prevents a muscle metaboreflex mediated increase in MCAVm. Indeed, the 80 
clamping of PETCO2 at baseline values during PEI following fatiguing static handgrip resulted in an 81 
elevation in MCAVm (13). 82 
The aforementioned studies possess limitations with regards to the assessment of cerebral blood 83 
flow and mode of muscle metaboreflex activation that we seek to address in the present investigation. 84 
First, for transcranial Doppler ultrasound measures of MCAVm to be representative of cerebral blood 85 
flow it must be assumed that MCA diameter remains constant. To circumvent this issue, direct measures 86 
of internal carotid artery (ICA) diameter (d), velocity (Vm) and thus ICA blood flow (ICAQ) can be 87 
employed, but to date the contribution of skeletal muscle afferents to the ICAQ responses to exercise 88 
remain unknown. Second, while the cerebral circulatory responses to muscle metaboreflex activation 89 
following exercise with PEI have been investigated, the responses to the enhanced muscle metaboreflex 90 
activation during exercise with BFR have not been considered. During PEI the muscle metaboreflex is 91 
activated in isolation from central command and skeletal muscle mechanoreflex (11, 16, 17). However, 92 
under clinical conditions such as peripheral vascular disease and chronic heart failure, where there is a 93 
hypoperfusion of the skeletal muscles, the muscle metaboreflex is not activated in isolation (7, 9, 24). 94 
Increasing metaboreflex signalling during exercise with BFR at the same time that central command and 95 
mechanoreflex are also activated would potentially provide a more realistic simulation of this paradigm. 96 
Furthermore, exercise with BFR is becoming an increasingly popular athletic training practice due to the 97 
potential for gains in muscle strength and endurance to occur without high-intensity training (54, 60). 98 
Spranger et al. (57) recently raised a ‘call for concern’ regarding the practice of exercise with BFR on 99 
the basis of the exaggerated increases in blood pressure and the associated risk of cardiovascular and 100 
cerebrovascular insult. At present the effects of BFR exercise on cerebral blood flow are unknown.  101 
Given this background, we sought to determine; 1) the influence of the muscle metaboreflex 102 
activation on cerebral blood flow, 2) if changes in PETCO2 are a key determinant of the cerebral blood 103 
flow response to muscle metaboreflex activation, and 3) whether the mode of muscle metaboreflex 104 
activation (i.e., during vs. following exercise) influences the corresponding cerebral blood flow 105 
response. To achieve this MCAVm and ICAQ were measured during exercise with BFR to enhance 106 
muscle metaboreflex activation and during isolated activation of the muscle metaboreflex with PEI. 107 
Trials were conducted where PETCO2 was permitted to fluctuate spontaneously and where PETCO2 was 108 
clamped at baseline values. We hypothesized that muscle metaboreflex activation would evoke an 109 
increase in MCAVm and ICAQ only when PETCO2 was clamped at baseline.  110 
METHODS 111 
 The study was approved by the Health, Safety and Ethics Committee of the School of Sport, 112 
Exercise and Rehabilitation Science at the University of Birmingham and was undertaken according to 113 
Declaration of Helsinki. Eleven male participants were recruited (age 25±4 years; height 180±1 cm; 114 
weight 71±7 kg; mean±SD). After receiving a detailed verbal and written explanation of the 115 
experimental protocol, all participants signed the consent form. All participants were free of any 116 
cardiovascular, respiratory, neurological, renal or metabolic diseases and were not using any 117 
prescription or over-the-counter medication. Abstinence of caffeinate beverages, alcohol or exercise was 118 
requested 24 hours prior to experimental sessions. The room temperature was kept constant at 20-22ºC, 119 
and external stimuli were kept to a minimum.  120 
 121 
Measurements 122 
Heart rate (HR) was monitored using lead II electrocardiogram and blood pressure was measured 123 
beat-to-beat from the middle finger of the right hand (Finometer Pro, Finapres Medical Systems, 124 
Arnhem, The Netherlands). Mean arterial pressure (MAP) was calculated offline by the integration of 125 
the arterial blood pressure waveform over a cardiac cycle. Resting blood pressure was verified by 126 
brachial artery blood pressure measurement made from the left arm using an automated 127 
sphygmomanometer (Tango+, SunTech Medical, USA). ICAVm and ICAd were measured from the left 128 
side of the neck with duplex Doppler ultrasound (Logiq, GE Medical Systems, Milwaukee, USA) using 129 
a 10-MHz multifrequency linear-array transducer with a constant insonation angle of 60º relative to the 130 
skin. ICA measurements were performed 1 to 1.5 cm distal to the carotid bifurcation while the subject’s 131 
chin was slightly elevated. To measure the ICAd the brightness mode was used in a longitudinal section, 132 
the systolic and diastolic diameters were measured over 10 cardiac cycles, the mean diameter was 133 
calculated as: Mean diameter (cm) = [(systolic diameter ×1/3)] + [(diastolic diameter ×2/3)]. The 134 
Doppler velocity spectrum was analyzed using the pulsed wave mode and the time-averaged mean flow 135 
velocity obtained over 10 cardiac cycles. The internal carotid blood flow (ICAQ; ml∙min-1) was 136 
calculated as [ICAVm × π × (diameter/2)2] x 60. ICA conductance (ICACVC; ml∙mim-1∙mmHg-1) was 137 
calculated as ICAQ/ MAP.  138 
MCAVm was measured with a 2 MHz pulse wave transcranial Doppler ultrasound system 139 
(Doppler Box X; Compumedics Germany GmbH, Singen, Germany). The MCA was insonated via the 140 
temporal window above the zygomatic arch on the left side of the head. After finding a satisfactory 141 
signal, the probe was fixed in place with a headband and ultrasonic gel. The MCA vascular conductance 142 
index (MCACVCi) was calculated as MCAVm /MAP.  143 
Participants wore a mouthpiece and nose-clip to permit breath-by-breath determination of minute 144 
ventilation (VE) via a turbine volume transducer (VMM400; Interface Associates, Aliso Viejo, CA, 145 
USA). The end-tidal partial pressures of O2 and CO2 were determined using rapid response gas 146 
analyzers (Moxus Modular; AEI Technologies Inc, Pittsburg, USA). Analog data were digitally 147 
converted at 1 kHz and stored on a PC for offline analysis (Powerlab and LabChart Pro; ADInstruments, 148 
Dunedin, New Zealand). 149 
 150 
Experimental Protocol 151 
An initial familiarization session was first conducted where the participants experienced all the 152 
experimental methods and protocols. The experimental protocol was subsequently conducted over two 153 
laboratory visits separated by 3-7 days with the order of protocol 1 and 2 (day 1 or 2) decided according 154 
to a coin toss. For each protocol, two trials were performed. In one trial, PETCO2 fluctuated normally 155 
while subjects breathed medical grade air, in another trial PETCO2 was clamped at ~1 mmHg above the 156 
resting partial pressure. Trials were counterbalanced and separated by a minimum of 20 min. PETCO2 157 
clamping was undertaken using a dynamic end-tidal forcing system which uses a prediction – correction 158 
system, whereby PETCO2 is controlled at the desired level by altering the composition of the inspired gas 159 
on a breath by breath basis (50). 160 
 161 
 162 
Protocol I: Leg cycling with BFR 163 
After instrumentation participants sat quietly in a semi-recumbent cycle ergometer and 164 
respiration was monitored for 10 min to determine the normal PETCO2. Participants were then instructed 165 
to commence cycling exercise at 60 rpm. During the first ~3 to 5 min the workload was adjusted to 166 
reach a target HR of 120 beats∙min-1 after which ~10 min of steady-state cycling exercise was performed 167 
(Ex1). Following this period, bilateral thigh cuffs were inflated to 130 mmHg (Rapid Cuff Inflation 168 
System E20 AG101, Hokanson, Bellevue, USA) in order to partially restrict blood flow to exercising 169 
muscles and engage the muscle metaboreflex (BFR). The thigh cuffs were deflated after 3 min and a 170 
further 3 min of steady-state cycling exercise was performed under free-flow conditions (Ex2). ICA 171 
assessments were not carried out during Ex2. Ratings of perceived exertion (RPE) were obtained using 172 
the 1-10 Borg scale (12) at the end of the Ex1, BFR, and Ex2 periods. Mean HR, BP, respiratory and 173 
MCAVm data were obtained on a beat-to-beat basis and averages calculated at rest (3 min), Ex1 (last 1 174 
min), BFR (last 1 min) and Ex2 (last 1 min). Ultrasound images for calculation of ICAQ were obtained 175 
during the last 1 min of rest, last 1 min of Ex1 and last 1 min of leg cycling with BFR. Measurements 176 
were then pooled to provide a mean value for each experimental phase. 177 
 178 
 179 
Protocol II: Leg cycling with PEI 180 
As described above, following a 10 min rest period during which the normal PETCO2 was 181 
determined, participants undertook cycling exercise on a semi-recumbent cycle ergometer (60 rpm). 182 
After a ~3-5 min period during which the workload was adjusted in order to reach the reach the target 183 
HR of 120 beats∙min-1 participants undertook steady-state cycling exercise for 10 min (Ex). Fifteen 184 
seconds before the end of the exercise, bilateral thigh cuffs were inflated to 300 mmHg in order to 185 
occlude the blood flow to the exercising muscles and remained inflated for 3 min in order to isolate the 186 
activation of the muscle metaboreflex (PEI). RPE was obtained after 5 min of steady-state cycling 187 
exercise. Mean HR, BP, respiratory and MCAVm data were obtained on a beat-to-beat basis and averages 188 
calculated at rest (3 min), Ex (last 1 min) and PEI (last 1 min). Ultrasound images for calculation of 189 
ICAQ were obtained during last 1 min of rest, last 1 min of Ex and last 1 min of PEI. Measurements 190 
were then pooled to provide a mean value for each experimental phase. 191 
 192 
Data and statistical analysis 193 
Values are reported as means ±SEM. Main effects of experimental phase (Rest, Ex, PEI or Rest, 194 
Ex1, BFR, Ex2), trial (control, PETCO2 clamp) and interaction (phase x trial) were made using two-way 195 
repeated measures ANOVA followed by Student-Newman-Keuls post hoc test. Between trial 196 
comparisons of exercise workload were made using Student t-tests. Statistical significance was set to 197 
p<0.05. Analyses were conducted using SigmaPlot 12.5 (Systat Software Inc, London, UK).198 
RESULTS 199 
Leg cycling with BFR 200 
The exercise workload was not different between trials (control 90±9 W and PETCO2 clamp trial 201 
85±9 W; P>0.05). In the control trial, PETCO2 was slightly increased from rest during leg cycling (Ex1 202 
Δ2.2±0.3 mmHg, P<0.05), decreased with BFR (Δ-4.8±0.9 mmHg, P<0.05), and returned to resting 203 
values upon the cessation of BFR (Ex2 Δ0.8±0.5 mmHg, P>0.05 vs. Rest; Figure 1). By design, in the 204 
clamp trial PETCO2 remained unchanged from the rest throughout all experimental phases. Leg cycling 205 
evoked similar increases in MCAVm during the control and PETCO2 clamp trials (P<0.05 Rest vs. Ex1; 206 
Figure 1). In the control trial, no change in MCAVm was observed during exercise with BFR, whereas in 207 
the PETCO2 clamp trial MCAVm was increased (P<0.05 vs. Rest, Ex1, and between conditions). In both 208 
trials, MCAVm was not different during leg cycling before and after BFR (P>0.05 Ex1 vs. Ex2). 209 
MCACVCi was unchanged from rest during leg cycling (P>0.05, Ex1 vs. Rest, Ex2 vs. Rest), but was 210 
decreased with BFR (P<0.05 vs. Rest and Ex1; Table 1). The magnitude of this decrease was greater in 211 
the control trial than in the PETCO2 clamp trial. ICAQ was unchanged from rest to leg cycling (Ex1) in 212 
both trials, but was increased with BFR in the PETCO2 clamp trial (P<0.05 vs. Rest and between trials; 213 
Figure 1), secondary to an increase in ICAVm. ICAd was unchanged throughout all experimental phases 214 
in both trials (Table 1). ICACVC was not different between trials and was similarly decreased from rest 215 
during leg cycling (P<0.05 Rest vs. Ex1) then further decreased during leg cycling with BFR (P<0.05 216 
Ex1 vs. Rest) in both trials.  217 
HR was not different between the control and PETCO2 clamp trials at any experimental phase 218 
(Table 1). MAP was slightly, but higher in the PETCO2 clamp trial (Figure 1). Leg cycling evoked 219 
increases in MAP, HR in both trials (P<0.05 Ex1 vs. Rest), which were further increased during BFR 220 
(P<0.05 vs. Ex1). During leg cycling following BFR, MAP and HR returned to values observed during 221 
leg cycling prior to BFR (Ex1 vs. Ex2, P>0.05). RPE was not different between the control trial [Ex1 222 
median, 4 (interquartile range, 4-5), BFR, 8 (7-8) and Ex2 5 (4-6); P<0.05] and the PETCO2 clamp trial 223 
[Ex1 4 (3-6), BFR 8, (7-8), Ex2 5 (4-7); P<0.05] (Wilcoxon signed-rank test). 224 
 225 
Leg cycling with PEI 226 
 Exercise workload was not different between trials (control 89± 9 W and PETCO2 clamp trial 227 
89±9 W; P>0.05). In the control trial, PETCO2 was unchanged from rest during leg cycling and 228 
decreased with PEI (Δ-7±1 mmHg, P<0.05; Figure 2), but by design, in the PETCO2 clamp trial it 229 
remained not different from rest throughout all experimental phases. In both the control and PETCO2 230 
clamp trials, MCAVm increased from rest during leg cycling (P≤0.05; Figure 2). During PEI, in the 231 
control trial MCAVm was not different from rest (P>0.05), whereas in the PETCO2 clamp trial MCAVm 232 
remained elevated (P<0.05 vs. rest and between trials). In the control trial, MCACVCi was not different 233 
from rest during leg cycling and was decreased from rest during PEI (P<0.05 vs. Rest and between 234 
trials; Table 2). MCACVCi was not different from rest throughout PETCO2 clamp trial (P>0.05; Table 2). 235 
ICAQ was not different from rest during leg cycling in both control and PETCO2 clamp trials (P>0.05; 236 
Figure 2). However, during PEI, ICAQ was higher in the PETCO2 clamp trial than in the control trial 237 
(P<0.05; Figure 2). ICAd was not different throughout all experimental phases in both trials (Table 2). 238 
ICACVC was greater in the PETCO2 clamp trial, but decreased similarly from rest during leg cycling 239 
(P<0.05 vs. Rest) in both trials. During PEI, ICACVC remained at levels sustained during exercise 240 
(P<0.05 vs. Rest, P>0.05 vs. Ex) in both trials. MAP and HR (Table 2; Figure 2) were not different 241 
between the control and PETCO2 clamp trials at any experimental phase. Leg cycling evoked increases in 242 
MAP and HR in both trials (P<0.05 vs. rest). In both trials, MAP was further increased with PEI from 243 
the level observed during leg cycling (P<0.05 vs. Rest and Ex), whereas HR fell, but remained above 244 
resting levels (P<0.05 vs. Rest and Ex).  245 
RPE were not different during leg cycling in the control [median, 5 (interquartile range, 4-7) and the 246 
PETCO2 clamp trials [5 (4-6)] (Wilcoxon signed-rank test).  247 
DISCUSSION 248 
The major novel finding of this study is that the muscle metaboreflex failed to elevate either 249 
MCAVm or ICAQ, when engaged by leg cycling with BFR or isolated during PEI following leg cycling 250 
under control conditions. However, a significant reduction in PETCO2, secondary to an increase in VE, 251 
was induced by muscle metaboreflex activation with either BFR or PEI. Accordingly, when PETCO2 was 252 
clamped at resting levels muscle metaboreflex-mediated increases in MCAVm and ICAQ were revealed 253 
during both BFR and PEI. Thus, in accordance with our original hypothesis, these findings demonstrate 254 
that when hyperventilation-related decreases in PETCO2 are prevented the muscle metaboreflex increases 255 
cerebral blood flow, and this occurs irrespective of the mode of muscle metaboreflex activation. 256 
A potential explanation why exercise with BFR, or indeed PEI, does not increase cerebral 257 
perfusion may be that the activation of metabolically sensitive skeletal muscle afferents evokes an 258 
increase in ventilation (5), which leads to a confounding reduction in PaCO2 (indexed by PETCO2). The 259 
contribution of group III and IV skeletal muscle afferents to the control of breathing remains 260 
controversial, nevertheless in agreement with several previous reports we observed an increase in VE 261 
during muscle metaboreflex activation (1, 13, 15, 44) and a reduction in PETCO2. CO2 is a powerful 262 
dilator of the cerebral vasculature (31) and decreases in PaCO2 lead to cerebral vasoconstriction (2). In 263 
the present study, the clamping of PETCO2 at resting levels unmasked a muscle metaboreflex-mediated 264 
increase in MCAVm and ICAQ during leg cycling with BFR and during PEI following leg cycling. 265 
Furthermore, the degree of cerebral vasoconstriction (i.e., the magnitude of the reduction in MCACVCi) 266 
during PEI and exercise with BFR was attenuated in the PETCO2 clamp trial, although a similar effect 267 
was not observed for ICACVC. These observations are in concordance with our earlier report that PEI 268 
following fatiguing ischemic handgrip exercise only increases MCAVm when PETCO2 is clamped at 269 
resting levels (13). Such observations may help to explain why others have not shown MCAVm to be 270 
elevated during PEI. Indeed, Jorgensen et al., (28) also reported that PaCO2 was decreased below resting 271 
levels during PEI following cycling exercise. In agreement with Friedman et al., (19, 20) and Jorgensen 272 
et al., (29), who demonstrated that pharmacological blockade of sensory feedback from skeletal muscle 273 
afferents diminished the increase in cerebral perfusion during exercise, the results of the present study 274 
support a role for the muscle metaboreflex in the regulation of cerebral blood flow during exercise. This 275 
may be attributable to the pairing of local neuronal activation and perfusion (i.e., neural-vascular 276 
coupling), that is to say cerebral flow increases in order to increase O2 delivery in accordance with 277 
increased metabolic. Studies employing advanced imaging techniques have shown that isolated 278 
metaboreflex stimulation (PEI) evokes increased activity in discrete brain regions (e.g., medial and 279 
lateral dorsal medulla, contralateral insula, primary and secondary somatosensory cortex) (53). It is 280 
acknowledged that part of the cerebrovascular responses to PEI arises on account of the discomfort 281 
associated with this manoeuvre (35). In the present study we are not able to quantify the contribution of 282 
local discomfort to the cerebrovascular responses to PEI and BFR, but note that without the clamping of 283 
PETCO2 at resting levels no changes in cerebral perfusion were observed. As such, the combination of 284 
PETCO2 clamping and brain imaging modalities may provide additional insights into the effects of 285 
muscle metaboreflex activation on regional brain activation. The influence of exercise-induced increases 286 
of MAP on cerebral blood flow is somewhat controversial. The observation that during PEI, MCAVm 287 
remains at resting levels while MAP is elevated is part of the reason why the direct influence of blood 288 
pressure on the exercise-induced increase of cerebral perfusion has on occasion been discounted (26, 47, 289 
55). However, when considering the effects of MAP on cerebral perfusion during exercise the 290 
potentially confounding effects of changes in PETCO2 should be considered. With PaCO2 controlled, 291 
MCAVm changes by ~0.8% per mmHg change in MAP within the so called “autoregulatory range” (34). 292 
We observed that, BFR evoked a 44 mmHg increase from rest in MAP and a 26% increase in MCAVm, 293 
while during PEI, MAP was elevated by 29 mmHg and MCAVm elevated by 17%. As such, increases in 294 
MAP may reasonably be expected to contribute, at least in part, for the observed increase in cerebral 295 
blood flow. The ventilatory response to leg cycling with BFR was enhanced when PETCO2 was clamped. 296 
As neither the exercise workload nor the thigh cuff pressure were different between conditions, it is 297 
unlikely that this is attributable to a difference in the degree of muscle afferent activation within the 298 
active skeletal muscles. However, in the absence of a direct assessment of local metabolites this 299 
possibility cannot be excluded. Alternatively, the clamping of PETCO2 may have eliminated part of the 300 
chemoreflex-mediated inhibition of the ventilatory response. It is possible that the greater ventilatory 301 
response to exercise observed when PETCO2 was clamped, could evoke a respiratory muscle 302 
metaboreflex and augment the concomitant blood pressure response (51). However, an exaggerated 303 
increase in blood pressure did not accompany the greater ventilatory response to exercise with BFR in 304 
the clamp trial. 305 
The present study extends earlier reports examining the contribution of skeletal muscle afferents 306 
to cerebral blood flow regulation in two important ways. Rather than relying on transcranial Doppler 307 
ultrasound measures of MCAVm to estimate cerebral perfusion, we have used duplex Doppler ultrasound 308 
measures of cerebral blood flow (ICAQ). In order that transcranial Doppler ultrasound measures of 309 
MCAVm are representative of cerebral blood flow, it must be assumed that MCAd remains constant. As 310 
such, this is the first study to determine the influence of the muscle metaboreflex activation on cerebral 311 
blood flow in humans. In addition to use of PEI to assess the effect of isolated skeletal muscle 312 
metaboreflex activation on cerebral blood flow, exercise with BFR was undertaken. As indicated above, 313 
this has applied relevance to those undertaking such practices to induce athletic enhancements, but also 314 
patient populations in whom muscle metaboreflex activation may be heightened during exercise as a 315 
consequence of skeletal muscle under-perfusion (e.g., chronic heart failure, peripheral vascular disease). 316 
Despite exercise with BFR and PEI evoking similar reductions from rest in PETCO2 (Δ-2.6 and Δ-5.0 317 
mmHg for BFR and PEI, respectively), MCAVm was significantly elevated from rest during exercise 318 
with BFR such that it was similar to that observed during free-flow exercise, whereas MCAVm was not 319 
different from rest during PEI. Such findings may be explained by a greater elevations in cardiac output 320 
and the concomitant activation of central command during exercise with BFR compared to PEI (36). 321 
Nevertheless, independent of the mode of muscle metaboreflex activation, when muscle metaboreflex 322 
mediated reductions in PETCO2 were prevented increases in cerebral blood flow were observed.  323 
Regular exercise with BFR (e.g., Kaatsu training) has been reported to enhance cardiorespiratory 324 
fitness (60) and skeletal muscle mass in healthy young and older individuals (32, 33, 63, 64), and 325 
patients (56). It is believed that exercise training with BFR exaggerates the normal accumulation of 326 
metabolites within the active skeletal muscle, thus promoting muscle growth and force generating 327 
capacity without the need for high-intensity training (21, 22, 43, 62). In a recent article, Spranger et al., 328 
(57) raised a ‘call for concern’ about this practice on the basis that it engages the muscle metaboreflex, 329 
which is known to powerfully increase sympathetic nerve activity to the heart and peripheral vasculature 330 
and can inhibit cardiac parasympathetic activity (18). As a consequence of these autonomic alterations, 331 
exercise with BFR evokes pronounced increases in peripheral vascular resistance, cardiac output and 332 
blood pressure (59). This could be of particular concern to patients in whom exaggerated skeletal 333 
muscle afferent sensitivity has been identified (e.g., hypertension, chronic heart failure, chronic 334 
obstructive pulmonary disease, type 2 diabetes) (7, 9, 24, 25, 45) and could raise the risk of 335 
cardiovascular and cerebrovascular events (57). Indeed, in the present study of healthy individuals, 336 
exercise with BFR raised MAP by ~27 mmHg and heart rate by ~22 beats∙min-1 from levels established 337 
during a preceding period of leg cycling under free-flow conditions. However, despite such 338 
hemodynamic alterations cerebral perfusion was unchanged during exercise with BFR, thus calling into 339 
question the contention that exercise with BFR may increase the risk of cerebrovascular injury as a 340 
consequence of a large local hyperaemic response. In fact we observed that exercise with BFR evoked a 341 
lower than expected cerebral blood flow, on account of the coincident hyperventilation and hypocapnia 342 
linked cerebral vasoconstriction. During high intensity dynamic exercise, particularly when combined 343 
with hypoxia, a reduced cerebral oxygenation has been postulated as a fatigue mechanism (8, 40, 55). 344 
As such, in patients who exhibit exaggerated skeletal muscle afferent feedback and an excessive 345 
hyperventilatory response to exercise (e.g., chronic heart failure, congestive obstructive pulmonary 346 
disease) (7, 9, 58), the associated reduction in PaCO2 and cerebral vasoconstriction may precipitate 347 
exercise intolerance via a central mechanism (41, 48). Future studies utilizing arterial-internal jugular 348 
venous blood sampling are required, particularly in chronic disease populations, to better understand 349 
how cerebral metabolism (e.g., O2 delivery, cerebral metabolic rate for O2, fractional O2 extraction) is 350 
affected by the activation of skeletal muscle afferents while PETCO2 is clamped at baseline levels. 351 
There are several limitations on the present study, PETCO2 was used as a surrogate for PaCO2, 352 
although during exercise PETCO2 could have overestimated PaCO2 (49) there is a strong correlation 353 
between PETCO2 and PaCO2 across all levels of physiologic dead space (37). We used external thigh 354 
cuffs to decrease/occlude blood flow to the legs, although no direct measures of the leg blood flow or 355 
local metabolite concentrations were possible, we observed marked increases in MAP during this 356 
manoeuvre indicative of muscle metaboreflex activation, which strongly suggest that reductions in 357 
blood flow were successfully induced. BFR may have increased in central command, which could have 358 
contributed to the increase of cerebral blood flow (6). Indeed, increases in RPE, historically related to 359 
central command (38, 39), were noted during leg cycling with BFR. Human studies are needed in which 360 
the cardiovascular and cerebrovascular responses to the application of BFR during leg cycling are 361 
evaluated before and after pharmacological inhibition of feedback from group III and IV skeletal muscle 362 
afferents (e.g., intrathecal fentanyl) in order to test the contribution of central command to this 363 
manoeuvre. Automated edge-tracking software was not used in the present study and this may be a 364 
limitation (61), although intraclass correlations between repeated rest and exercise measures made 365 
during a study visit were high (i.e., >0.8). Finally, we have only evaluated the effect of skeletal muscle 366 
afferent feedback with BFR during moderate cycling exercise, and care should be taken when directly 367 
extrapolating our findings to other exercise intensities and modalities. This is important in light of the 368 
concept that athletes may utilise BFR training in order to try to obtain a desirable training effects but at a 369 
lower exercise intensity (21, 22, 43, 62). 370 
In conclusion, the findings of the present study indicate that only when hyperventilation-related 371 
decreases in PETCO2 are prevented does the activation of metabolically sensitive skeletal muscle afferent 372 
fibres evoke an increase in cerebral blood flow, irrespective of the mode of activation (i.e. during or 373 
following Ex). 374 
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  557 
FIGURE LEGENDS 558 
Figure 1. Cardiorespiratory and cerebrovascular responses to leg cycling under free-flow 559 
conditions (Ex1, Ex2) and with blood flow restriction (BFR). Partial pressure of end-tidal carbon 560 
dioxide (PETCO2); middle cerebral artery blood velocity (MCAVm); internal carotid artery blood flow 561 
(ICAQ); mean arterial pressure (MAP). Ex, exercise; BFR, blood flow restriction. Values are 562 
mean±SEM. * P<0.05 vs. rest, †P<0.05 vs. Ex1, ‡P<0.05 vs. control. 563 
 564 
Figure 2. Cardiorespiratory and cerebrovascular responses to leg cycling and post-exercise 565 
ischemia (PEI). Partial pressure of end-tidal carbon dioxide (PETCO2); middle cerebral artery blood 566 
velocity (MCAVm); internal carotid artery blood flow (ICAQ); mean arterial pressure (MAP). Ex, 567 
exercise; PEI, post exercise ischemia. Values are mean±SEM. * P<0.05 vs. rest, †P<0.05 vs. Ex, 568 
‡P<0.05 vs. control. 569 
Table 1. Cardiorespiratory and cerebrovascular responses to leg cycling under free-flow conditions (Ex1, Ex2) and with blood flow restriction 0 
(BFR) 1 
  Experimental Phase  P value 
  Rest Ex1 BFR Ex2  Phase Condition Interaction 
VE (l∙min-1)                
Control  9 ± 1 35 ± 2* 45 ± 3*† 39 ± 2*  <0.001 0.002 0.002 
PETCO2 Clamp  11 ± 2 37 ± 3* 56 ± 4*†‡ 46 ± 3*†‡  
MCACVCi  (cm∙s-1∙mmHg-1)                
Control  0.66 ± 0.06 0.65 ± 0.05 0.49 ± 0.03*† 0.66 ± 0.06  
<0.001 0.927 0.026 
PETCO2 Clamp  0.67 ± 0.06 0.63 ± 0.04 0.54 ± 0.04*†‡ 0.63 ± 0.06  
ICAVm (cm∙s-1)                
Control  28 ± 1 28 ± 1 26 ± 1     
0.573 0.007 0.003 
PETCO2 Clamp  28 ± 1 29 ± 2* 31 ± 1*†‡     
ICAd (cm)                
Control  0.46 ± 0.01 0.45 ± 0.01 0.45 ± 0.01     
0.467 0.486 0.213 
PETCO2 Clamp  0.45 ± 0.01 0.45 ± 0.01 0.46 ± 0.01     
ICACVC (ml∙min-1∙mmHg-1)                
Control  3.3 ± 0.2 2.9 ± 0.2 2.0 ± 0.1     
<0.001 0.321 0.108 
PETCO2 Clamp  3.2 ± 0.2 2.8 ± 0.2 2.4 ± 0.1     
SBP (mmHg)                
Control  117 ± 2 153 ± 7 191 ± 8 146 ± 7  
<0.001 0.611 0.402 
PETCO2 Clamp  115 ± 3 153 ± 5 195 ± 6 146 ± 6  
DBP (mmHg)                
Control  67 ± 3 72 ± 3 96 ± 3 75 ± 4  
<0.001 <0.001 0.522 
PETCO2 Clamp  70 ± 2 79 ± 3 101 ± 5 80 ± 3  
HR (beats∙min-1)                
Control  64 ± 3 122 ± 1 144 ± 3 124 ± 2  
<0.001 0.450 0.760 
PETCO2 Clamp  65 ± 3 121 ± 1 145 ± 2 125 ± 2  
Values are mean±SEM. VE, ventilation; MCACVCi, middle cerebral artery conductance; ICAVm, internal carotid artery mean velocity; ICAd, 2 
internal carotid artery diameter; ICACVC, internal carotid artery conductance; SBP, systolic blood pressure; MAP, mean arterial pressure; HR, 3 
heart rate; Ex, exercise; BFR, blood flow restriction. Values are mean ± SEM. * P<0.05 vs. Rest, †P<0.05 vs. Ex1, ‡P<0.05 vs. Control. 4 
 5 
  6 
Table 2. Cardiorespiratory and cerebrovascular responses to leg cycling and post-exercise ischemia (PEI) 7 
  Experimental Phase  P value 
  Rest Ex PEI  Phase Condition Interaction 
VE (l∙min-1)            
Control  9 ± 1 40 ± 2* 16 ± 3†  <0.001 0.011 0.001 
PETCO2 Clamp  13 ± 1 40 ± 3* 25 ± 3*†‡  
MCACVCi (cm∙s-1∙mmHg-1)            
Control  0.60 ± 0.05 0.55 ± 0.03 0.43 ± 0.03*†  
0.001 0.004 0.031 
PETCO2 Clamp  0.64 ± 0.04 0.59 ± 0.04 0.56 ± 0.04‡  
ICAVm (cm∙s-1)              
Control  25 ± 1 26 ± 1 23 ± 2  
0.735 <0.001 0.019 
PETCO2 Clamp  27 ± 1 28 ± 1 29 ± 2‡  
ICAd (cm)            
Control  0.45 ± 0.01 0.45 ± 0.01 0.45 ± 0.01  
0.306 0.572 0.784 
PETCO2 Clamp  0.46 ± 0.01 0.45 ± 0.01 0.45 ± 0.01  
ICACVC (ml∙min-1∙mmHg-1)            
Control  2.8 ± 0.2 2.4 ± 0.2 1.9 ± 0.2  <0.001 <0.001 0.122 
PETCO2 Clamp  3.1 ± 0.2 2.6 ± 0.1 2.5 ± 0.2     
SBP (mmHg)            
Control  118 ± 4 155 ± 7 145 ± 7  
<0.001 0.729 0.469 
PETCO2 Clamp  116 ± 4 159 ± 9 148 ± 8  
DBP (mmHg)            
Control  72 ± 3 83 ± 4 98 ± 5  
<0.001 0.157 0.932 
PETCO2 Clamp  69 ± 2 80 ± 3 94 ± 3  
HR (beats∙min-1)               
Control  61 ± 3 121 ± 2 95 ± 5  
<0.001 0.764 0.416 
PETCO2 Clamp  63 ± 3 123 ± 1 93 ± 3  
Values are mean±SEM. VE, ventilation; MCACVC, middle cerebral artery conductance; ICAVm, internal carotid artery mean velocity; 8 
ICAd, internal carotid artery diameter; ICACVCi, internal carotid artery conductance; SBP, systolic blood pressure; MAP, mean arterial 9 
pressure; HR, heart rate; Ex, exercise; PEI, post exercise ischemia. Values are mean ± SEM. * P<0.05 vs. Rest, †P<0.05 vs. Ex, 0 
‡P<0.05 vs. Control. 1 
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